On October 14, 2010, FDA warned eight companies that market over-the-counter chelation products that these are unapproved drugs and devices and that it is a violation of federal law to make false claims about the products.
Source: http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm228685.htm
supplier Docetaxel Docetaxel clinical trial Docetaxel structure